基于模型的药物研发提高生产力：企业视角 - Suppr

Suppr

超能文献

Improving productivity with model-based drug development: an enterprise perspective.

作者信息

Grasela T H, Slusser R

机构信息

Cognigen Corporation, Buffalo, New York, USA.

出版信息

Clin Pharmacol Ther. 2010 Aug;88(2):263-8. doi: 10.1038/clpt.2010.117. Epub 2010 Jun 30.

DOI:10.1038/clpt.2010.117

PMID:20592720

Abstract

摘要

相似文献

Improving productivity with model-based drug development: an enterprise perspective.

Clin Pharmacol Ther. 2010 Aug;88(2):263-8. doi: 10.1038/clpt.2010.117. Epub 2010 Jun 30.

Pharmacometrics and the transition to model-based development.

Clin Pharmacol Ther. 2007 Aug;82(2):137-42. doi: 10.1038/sj.clpt.6100270.

Next-generation model-based drug discovery and development: quantitative and systems pharmacology.

Clin Pharmacol Ther. 2010 Jul;88(1):135-7. doi: 10.1038/clpt.2010.81. Epub 2010 Jun 9.

How should we support pharmaceutical innovation?

Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):313-20. doi: 10.1586/erp.09.34.

The economics of drug development: a grim reality and a role for clinical pharmacology.

Clin Pharmacol Ther. 2010 Mar;87(3):247-51. doi: 10.1038/clpt.2009.298.

An assessment of R&D productivity in the pharmaceutical industry.

Trends Pharmacol Sci. 2011 Dec;32(12):683-5. doi: 10.1016/j.tips.2011.09.005. Epub 2011 Oct 24.

Overcoming the obstacles in the pharma/biotech industry: 2008 update.

Drug News Perspect. 2009 Jan-Feb;22(1):39-51. doi: 10.1358/dnp.2009.22.1.1303817.

ASCPT Task Force for advancing pharmacometrics and integration into drug development.

Clin Pharmacol Ther. 2010 Aug;88(2):158-61. doi: 10.1038/clpt.2010.141.

Clinical trial simulation: a review.

Clin Pharmacol Ther. 2010 Aug;88(2):166-82. doi: 10.1038/clpt.2010.114. Epub 2010 Jul 7.

Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.

Clin Pharmacol Ther. 2010 Aug;88(2):141-4. doi: 10.1038/clpt.2010.136.

引用本文的文献

Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care.

Clin Transl Sci. 2018 Sep;11(5):450-460. doi: 10.1111/cts.12559. Epub 2018 May 16.

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):418-429. doi: 10.1002/psp4.12196. Epub 2017 Jul 19.

Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in Psoriasis.

CPT Pharmacometrics Syst Pharmacol. 2013 Jul 24;2(7):e58. doi: 10.1038/psp.2013.32.

Has the time come for predictive computer modeling in CNS drug discovery and development?

CPT Pharmacometrics Syst Pharmacol. 2012 Nov 28;1(11):e16. doi: 10.1038/psp.2012.17.

Agent-based modeling: a systematic assessment of use cases and requirements for enhancing pharmaceutical research and development productivity.

Wiley Interdiscip Rev Syst Biol Med. 2013 Jul-Aug;5(4):461-80. doi: 10.1002/wsbm.1222. Epub 2013 Jun 4.

Advancing pharmacometrics and systems pharmacology.

Clin Pharmacol Ther. 2012 Nov;92(5):535-7. doi: 10.1038/clpt.2012.151.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Improving productivity with model-based drug development: an enterprise perspective.

Clin Pharmacol Ther. 2010 Aug;88(2):263-8. doi: 10.1038/clpt.2010.117. Epub 2010 Jun 30.

Pharmacometrics and the transition to model-based development.

Clin Pharmacol Ther. 2007 Aug;82(2):137-42. doi: 10.1038/sj.clpt.6100270.

Next-generation model-based drug discovery and development: quantitative and systems pharmacology.

Clin Pharmacol Ther. 2010 Jul;88(1):135-7. doi: 10.1038/clpt.2010.81. Epub 2010 Jun 9.

How should we support pharmaceutical innovation?

Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):313-20. doi: 10.1586/erp.09.34.

The economics of drug development: a grim reality and a role for clinical pharmacology.

Clin Pharmacol Ther. 2010 Mar;87(3):247-51. doi: 10.1038/clpt.2009.298.

An assessment of R&D productivity in the pharmaceutical industry.

Trends Pharmacol Sci. 2011 Dec;32(12):683-5. doi: 10.1016/j.tips.2011.09.005. Epub 2011 Oct 24.

Overcoming the obstacles in the pharma/biotech industry: 2008 update.

Drug News Perspect. 2009 Jan-Feb;22(1):39-51. doi: 10.1358/dnp.2009.22.1.1303817.

ASCPT Task Force for advancing pharmacometrics and integration into drug development.

Clin Pharmacol Ther. 2010 Aug;88(2):158-61. doi: 10.1038/clpt.2010.141.

Clinical trial simulation: a review.

Clin Pharmacol Ther. 2010 Aug;88(2):166-82. doi: 10.1038/clpt.2010.114. Epub 2010 Jul 7.

Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.

Clin Pharmacol Ther. 2010 Aug;88(2):141-4. doi: 10.1038/clpt.2010.136.

引用本文的文献

Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care.

Clin Transl Sci. 2018 Sep;11(5):450-460. doi: 10.1111/cts.12559. Epub 2018 May 16.

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):418-429. doi: 10.1002/psp4.12196. Epub 2017 Jul 19.

Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in Psoriasis.

CPT Pharmacometrics Syst Pharmacol. 2013 Jul 24;2(7):e58. doi: 10.1038/psp.2013.32.

Has the time come for predictive computer modeling in CNS drug discovery and development?

CPT Pharmacometrics Syst Pharmacol. 2012 Nov 28;1(11):e16. doi: 10.1038/psp.2012.17.

Agent-based modeling: a systematic assessment of use cases and requirements for enhancing pharmaceutical research and development productivity.

Wiley Interdiscip Rev Syst Biol Med. 2013 Jul-Aug;5(4):461-80. doi: 10.1002/wsbm.1222. Epub 2013 Jun 4.

Advancing pharmacometrics and systems pharmacology.

Clin Pharmacol Ther. 2012 Nov;92(5):535-7. doi: 10.1038/clpt.2012.151.